For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of TRIDENT LIFELINE. For more details, see the TRIDENT LIFELINE quarterly results and TRIDENT LIFELINE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.7 |
No. of shares | m | 11.50 |
1 Week | % | -4.3 |
1 Month | % | -6.9 |
1 Year | % | 6.9 |
52 week H/L | Rs | 239.7/128.3 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
TRIDENT LIFELINE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 180 | ||
Low | Rs | NA | NA | NA | 103 | ||
Sales per share (Unadj.) | Rs | 15.9 | 19.2 | 27.2 | 27.6 | ||
Earnings per share (Unadj.) | Rs | -2.6 | 1.3 | 4.9 | 5.2 | ||
Diluted earnings per share | Rs | -0.7 | 0.5 | 3.4 | 5.2 | ||
Cash flow per share (Unadj.) | Rs | -2.2 | 1.6 | 5.2 | 5.5 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | -9.7 | -0.9 | 6.0 | 39.7 | ||
Adj. book value per share | Rs | -2.6 | -0.4 | 4.2 | 39.7 | ||
Shares outstanding (eoy) | m | 3.10 | 5.00 | 8.00 | 11.50 | ||
Price / Sales ratio | x | 0 | 0 | 0 | 5.1 | ||
Avg P/E ratio | x | 0 | 0 | 0 | 27.0 | ||
P/CF ratio (eoy) | x | 0 | 0 | 0 | 25.5 | ||
Price / Book Value ratio | x | 0 | 0 | 0 | 3.6 | ||
Dividend payout | % | 0 | 0 | 0 | 0 | ||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 1,625 | ||
Total wages/salary | Rs m | 7 | 7 | 11 | 13 |
TRIDENT LIFELINE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 49 | 96 | 218 | 317 | ||
Other income | Rs m | 1 | 2 | 6 | 12 | ||
Total revenues | Rs m | 50 | 98 | 224 | 329 | ||
Gross profit | Rs m | -3 | 13 | 27 | 63 | ||
Depreciation | Rs m | 1 | 1 | 2 | 4 | ||
Interest | Rs m | 8 | 4 | 1 | 5 | ||
Profit before tax | Rs m | -11 | 9 | 30 | 66 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | -3 | 2 | -10 | 6 | ||
Profit after tax | Rs m | -8 | 6 | 39 | 60 | ||
Gross profit margin | % | -5.5 | 13.0 | 12.4 | 19.8 | ||
Effective tax rate | % | 25.9 | 25.9 | -32.3 | 8.6 | ||
Net profit margin | % | -16.1 | 6.6 | 18.1 | 19.0 |
TRIDENT LIFELINE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 28 | 77 | 107 | 489 | ||
Current liabilities | Rs m | 29 | 73 | 76 | 113 | ||
Net working cap to sales | % | -0.8 | 4.2 | 14.2 | 118.6 | ||
Current ratio | x | 1.0 | 1.1 | 1.4 | 4.3 | ||
Inventory Days | Days | 54 | 26 | 11 | 43 | ||
Debtors Days | Days | 971 | 241 | 833 | 1,396 | ||
Net fixed assets | Rs m | 15 | 19 | 21 | 94 | ||
Share capital | Rs m | 31 | 50 | 80 | 115 | ||
"Free" reserves | Rs m | -61 | -55 | -32 | 341 | ||
Net worth | Rs m | -30 | -5 | 48 | 456 | ||
Long term debt | Rs m | 65 | 45 | 14 | 22 | ||
Total assets | Rs m | 43 | 96 | 128 | 587 | ||
Interest coverage | x | -0.4 | 3.1 | 24.7 | 14.6 | ||
Debt to equity ratio | x | -2.2 | -9.6 | 0.3 | 0 | ||
Sales to assets ratio | x | 1.1 | 1.0 | 1.7 | 0.5 | ||
Return on assets | % | -0.8 | 10.9 | 31.7 | 11.1 | ||
Return on equity | % | 26.5 | -134.2 | 82.7 | 13.2 | ||
Return on capital | % | -9.1 | 31.2 | 50.2 | 14.8 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0 | 0 | 0 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | ||
Fx inflow | Rs m | 24 | 88 | 165 | 168 | ||
Fx outflow | Rs m | 1 | 2 | 6 | 5 | ||
Net fx | Rs m | 24 | 86 | 159 | 163 |
TRIDENT LIFELINE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -6 | 15 | -2 | -174 | ||
From Investments | Rs m | -1 | -6 | -4 | -69 | ||
From Financial Activity | Rs m | 8 | -10 | 8 | 380 | ||
Net Cashflow | Rs m | 1 | -0 | 1 | 136 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Hardik Jigishkumar Desai | COMP SEC: Jiteshkumar Ramchandra Varkal | YEAR OF INC: 2014 | BSE CODE: 543616 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare TRIDENT LIFELINE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.